Effect of sorafenib combined with cytostatic agents on hepatoblastoma cell lines and xenografts

BACKGROUND: Sorafenib has recently been shown to reduce tumour growth in hepatoblastoma (HB) xenografts. The effect of a combined administration with cytostatic agents was now investigated. METHODS: Cell viability after treatment with sorafenib and different cytostatic agents was evaluated in two HB...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Eicher, C, Dewerth, A, Thomale, J, Ellerkamp, V, Hildenbrand, S, Warmann, S W, Fuchs, J, Armeanu-Ebinger, S
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 2013
Matèries:
Translational Therapeutics
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3566826/
https://ncbi.nlm.nih.gov/pubmed/23257893
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2012.539
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars